Additionally, it is acknowledged that, while the purity of ASGR1+ EVs in control EV preparations (Figure S3 and Table S1) was extensively characterised, limitations regarding sample volume precluded comparable analyses in the NAFL and NASH samples. This evidence concerns the gene ASGR1 and metabolic dysfunction-associated steatohepatitis.